← Leaderboards
Christopher E Forsmark
University Of Florida
$2,643,269
Attributed
$6,947,118
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $888.6K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,947,118 · 5
By mechanism
U01$6,455,774 · 3
M01$491,344 · 2
Top collaborators
- Steven J Hughes21 shared
- Kenneth Cusi14 shared
- Richard E Pratley7 shared
Most similar at University Of Florida
Same institution · by research overlap
- I. David Weiner$7,485,622
- Jill V Reed$610,200
- Clayton E Mathews$19,414,489
- Phillip P Toskes$1,841,794
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchCohortPancreatitisSamplingResourcesDiabetes MellitusPancreasAcute PancreatitisBiological MarkersUniversitiesInsulinFloridaEffective TherapyRisk FactorsAreaInsulin ResistanceRelapseChronic PancreatitisInsulin DeficiencyPreventionOperative Surgical ProceduresRecruitEarly DiagnosisPancreatic Diseases
Grant awards (25)
Continuation of Type 1 Diabetes in Acute Pancreatitis Consortium â UF Health and AdventHealth Combined Clinical Center$452,769
U01 · FY2025 · DK · contact PI
The Chronic Pancreatitis Clinical Research Consortium$435,853
U01 · FY2025 · DK · contact PI
U-01 CONSORTIUM FOR THE STUDY OF CHRONIC PANCREATITIS,DIABETES AND PANCREATIC CANCER CLINICAL CENTERS$437,436
U01 · FY2024 · DK · contact PI
Type 1 Diabetes in Acute Pancreatitis Consortium - Clinical Centers$195,129
U01 · FY2024 · DK · contact PI
U-01 CONSORTIUM FOR THE STUDY OF CHRONIC PANCREATITIS,DIABETES AND PANCREATIC CANCER CLINICAL CENTERS$455,662
U01 · FY2023 · DK · contact PI
Type 1 Diabetes in Acute Pancreatitis Consortium - Clinical Centers$197,394
U01 · FY2023 · DK · contact PI
PROCEED + DETECT Year 9 supplement patient care costs$135,000
U01 · FY2023 · DK · contact PI
U-01 CONSORTIUM FOR THE STUDY OF CHRONIC PANCREATITIS,DIABETES AND PANCREATIC CANCER CLINICAL CENTERS$455,662
U01 · FY2022 · DK · contact PI
Type 1 Diabetes in Acute Pancreatitis Consortium - Clinical Centers$197,394
U01 · FY2022 · DK · contact PI
U-01 CONSORTIUM FOR THE STUDY OF CHRONIC PANCREATITIS,DIABETES AND PANCREATIC CANCER CLINICAL CENTERS$90,400
U01 · FY2022 · DK · contact PI
U-01 CONSORTIUM FOR THE STUDY OF CHRONIC PANCREATITIS,DIABETES AND PANCREATIC CANCER CLINICAL CENTERS$455,662
U01 · FY2021 · DK · contact PI
Type 1 Diabetes in Acute Pancreatitis Consortium - Clinical Centers$198,491
U01 · FY2021 · DK · contact PI
U-01 CONSORTIUM FOR THE STUDY OF CHRONIC PANCREATITIS,DIABETES AND PANCREATIC CANCER CLINICAL CENTERS$455,662
U01 · FY2020 · DK · contact PI
Type 1 Diabetes in Acute Pancreatitis Consortium - Clinical Centers$212,696
U01 · FY2020 · DK · contact PI
U-01 CONSORTIUM FOR THE STUDY OF CHRONIC PANCREATITIS,DIABETES AND PANCREATIC CANCER CLINICAL CENTERS$90,400
U01 · FY2020 · DK · contact PI
U01-Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Clinical Centers$359,850
U01 · FY2019 · DK · contact PI
Administrative Supplement (NoD)$127,845
U01 · FY2019 · DK · contact PI
U01-Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Clinical Centers$373,553
U01 · FY2018 · DK · contact PI
U01-Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Clinical Centers$388,805
U01 · FY2017 · DK · contact PI
U01-Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Clinical Centers$382,431
U01 · FY2016 · DK · contact PI
U01-Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Clinical Centers$357,680
U01 · FY2015 · DK · contact PI
SAFETY &EFFICACY OF INHIBITION OF GASTRIC ACID SECRETION BY IV PANTO$207,281
M01 · FY2000 · RR
INHIBITION OF GASTRIC ACID SECRETION BY INTRAVENOUS PANTOPRAZOLE$207,281
M01 · FY2000 · RR
SAFETY &EFFICACY OF INHIBITION OF GASTRIC ACID SECRETION BY IV PANTO$38,391
M01 · FY2000 · RR
INHIBITION OF GASTRIC ACID SECRETION BY INTRAVENOUS PANTOPRAZOLE$38,391
M01 · FY2000 · RR